Zuora (NYSE: ZUO) helps businesses transition from one-time product sales to a subscription-based business model by providing software that makes this change hassle-free. Its offerings have gained popularity as they allow businesses to enjoy a recurring revenue stream, which of
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
The stock market is officially in bear market territory after falling more than 20% over the last two months. This is not a time to panic, as bear markets have occurred numerous times in previous decades. However, this can be a good opportunity to reassess your stock holdings
With the bulls running for the exits as the markets sink into a bear market, some growth stocks are selling at tempting valuations right now. No one knows how long this bear market will last. It could last for months, or the markets could snap back in a matter of weeks. If anyon
The novel coronavirus outbreak has sent the stock market packing over the past few weeks. While the possibility of further downside is always a risk, the recent crash has opened up a nice opportunity for value-oriented investors to start building positions in top-quality compani
(RTTNews) - Goldman Sachs Group Inc. (GS) disclosed in a regulatory filing that its Chief Executive Officer received David Solomon $27.5 million in compensation for 2019, up from $23.0 million compensation in 2018.
Let's face it: Being cooped up at home isn't easy, but with COVID-19 closing schools and shutting down businesses, that's the situation most of us are in. Even if you're busy doing your job remotely and caring for children, you might still reach a point when you're desperate for
I should have known things would go sideways when I saw my stockbroker playing a bit part on prime-time TV. That's when I learned he had two jobs -- stockbroker by day, and actor, also by day. To be fair, he did have a partner at the brokerage firm, who was probably the brains b
(RTTNews) - Boeing Co. (BA) announced that its chief executive Dave Calhoun and Board Chairman Larry Kellner will forego all pay until the end of 2020 to navigates COVID-19 crisis.
When you work hard your entire life, you want a comfortable retirement to look forward to -- and that means having enough money to pay your bills with enough left over for leisure and entertainment. But if you fall victim to these blunders, you could wind up in the opposite scen
These are unprecedented times. U.S. stocks peaked in mid-February and then lost almost 30% of their value in the second-shortest period of time in the past 50 years. Only the Black Monday crash in 1987, which knocked down the S&P 500 by 20% in a single day, resulted in a qu
In a blog post on Friday, Netflix's (NASDAQ: NFLX) chief content officer Ted Sarandos said the streaming giant has established a $100 million fund to help support the hourly workers that support many of its projects.
Healthcare organizations are working on a number of different types of treatments for COVID-19, repurposing old drugs, as well as developing new ones. However, the Food and Drug Administration (FDA) confirmed that it's working on developing a new type of treatment using the bloo
Despite the cannabis industry's struggles, sales in its most important fully legalized market continue to grow. On Friday, Statistics Canada released its latest set of economic data, revealing that sales of licensed cannabis increased by 4.3% in January on a month-over-month bas
Amneal Pharmaceuticals (NYSE: AMRX) announced on Friday that it would be ramping up production of its malaria drug, hydroxychloroquine sulfate, for potential use in treating COVID-19 patient symptoms. The company estimates that it will be able to manufacture around 20 million ta
Despite what President Donald Trump said at a White House briefing on Thursday, the Food and Drug Administration (FDA) hasn't approved chloroquine and its less-potent-but-safer offspring, hydrochloroquine, to treat COVID-19, the disease caused by the new coronavirus.
The coronavirus pandemic has been roiling oil markets. On its third worst day on record, the U.S. West Texas Intermediate crude plunged 24.4% to settle at $20.37 per barrel on Mar 18. This also marked the index’s lowest since February 2002. Meanwhile, slipping to the lowest l